Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well oxaliplatin works in treating young patients with
recurrent solid tumors that have not responded to previous treatment. Drugs used in
chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing
so they stop growing or die.